HeartSine Samaritan PAD Defibrillators Recalled for Test Configuration Flaw
HeartSine samaritan PAD defibrillators shipped in test configuration may have incorrect CPR timing and delayed or no therapy delivery in cardiac events. Users should stop using affected units and contact the manufacturer.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a life-critical medical device with potential for serious harm, including failure to deliver or delayed delivery of defibrillation therapy during cardiac emergencies. However, no reported illnesses or injuries are documented in the source, making this a theoretical risk-of-harm scenario. Per the rubric, risk-of-harm products without reported injury warrant a score of 3 (High).
Plain-English summary
HeartSine samaritan PAD (Public Access Defibrillator) models, including SAM 350P, SAM 360P, SAM 450P, and SAM 500P, have been recalled by the FDA due to a test configuration issue. The affected defibrillators were shipped in an improper test configuration rather than a production-ready state.
Devices affected by this configuration may display incorrect language, provide incorrect CPR duration instructions (prompting only 5-second intervals), and analyze heart rhythm at inappropriate intervals. This could result in delayed delivery or complete failure to deliver defibrillation therapy during cardiac emergencies, creating a serious risk to patient safety.
The recall affects 12 units with distribution across the United States (Texas, California, Illinois, Colorado, Florida, North Carolina, and Michigan) and internationally (Netherlands, Japan, and New Zealand).
Users and healthcare facilities should immediately discontinue use of any affected defibrillators and contact HeartSine Technologies Ltd for instructions on returning the devices or obtaining service replacements.
The recalled product
- Product
- HeartSine samaritan PAD (Public Access Defibrillator): Type/Catalog: SAM 350P/350-UNIT-US-10, 350-STR-US-10, 350-STR-UK-10; SAM 360P/360-STR-JA-10, 360-STR-DE-10, 360-STR-UK-10; SAM 450P/450-UNIT-US-08, ; SAM 500P/500-BAS-UK-10
- Manufacturer
- HeartSine Technologies Ltd
- Category
- Medical Device — Defibrillator
- Hazard
- device-malfunction
- cpr-timing-error
- delayed-therapy
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Type/UDI-DI or GTIN/Serial Number: SAM 350P/05060167120671
- 05060167127670
- +M727SAM350P0/$$+7/17D00023014
- 18D00020508
- 19D00017655
- 20D00006524
- 21D91081653
- 22D91152391
- SAM 360P/05060167127687
- 05060167127311
- 5060167122927/21E91049810
- 23E90001379
- 23E90010409
- SAM 450P/05060167129773
- +M727SAM450P0/$$+7
- +M727SAM450P0/$$+7/17G00001893
- 18G00001553
- SAM 500P/05060167122453/22B91071233
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- HighAzurion X-ray System Deaeration Hose May Degrade and Cause Oil Leakage
FDA (Devices) · 2026-05-27
- SevereMedtronic DLP Retrograde Cannula recalled for sterile barrier breach risk
FDA (Devices) · 2026-05-27
- SevereMedtronic DLP Retrograde Cannula Recalls for Sterile Barrier Breach Risk
FDA (Devices) · 2026-05-27
- HighSwan-Ganz Jr Catheter models recalled due to lumen hub leakage
FDA (Devices) · 2026-05-27
- HighMedtronic DLP Retrograde Cannula Cardiopulmonary Bypass Catheter Recall
FDA (Devices) · 2026-05-27